ApoB siRNA-induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5) - Bertin Instruments

    Scientific publications

    ApoB siRNA-induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5)

    Brandon Ason(14)brandon.ason@amgen.comJose Castro-Perez(23)Samnang Tep(1)Alice Stefanni(2)Marija Tadin-Strapps(1)Thomas Roddy(2)Thomas Hankemeier(3)Brian Hubbard(2)Alan B. Sachs(1)W. Michael Flanagan(1)Nelly A. Kuklin(1)Lyndon J. Mitnaul(2)
    Sources: 1.Sirna Therapeutics/Merck & Co. Inc., San Francisco, CA 94158, USA2.Division of Cardiovascular Diseases and Atherosclerosis, Merck Research Laboratories, Rahway, NJ 07065, USA3.Division of Analytical Biosciences, LACDR, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands4.Amgen Inc., 1120 Veterans Blvd, San Francisco, CA 94080, USA
    Lipids (2011) 46:991-1003DOI 10.1007/s11745-011-Life Sciences96-3

    Sample name

    Animal tissues (mice)

    Kits

    CK14_2mL

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question